Caligan Partners LP - Apr 6, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
10%+ Owner
Signature
Caligan Partners LP, By: /s/ David Edward Johnson, Partner
Stock symbol
LAB
Transactions as of
Apr 6, 2022
Transactions value $
$1,922,463
Form type
4
Date filed
4/8/2022, 05:19 PM
Previous filing
May 10, 2021
Next filing
Apr 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock, $0.001 par value per share ("Common Stock") Purchase $394K +110K +1.31% $3.60 8.49M Apr 6, 2022 See footnote F1
transaction LAB Common Stock Purchase $776K +200K +2.36% $3.88 8.69M Apr 7, 2022 See footnote F1
transaction LAB Common Stock Purchase $752K +200K +2.3% $3.76 8.89M Apr 8, 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Remarks:

The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.